Lv1
30 积分 2025-12-10 加入
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
1个月前
已完结
Performance of the Aspartate Aminotransferase-to-Platelet Ratio Index for the Staging of Hepatitis C-Related Fibrosis: An Updated Meta-Analysis §Δ
4个月前
已完结
Association between cardiometabolic index and controlled attenuation parameter in U.S. adults with NAFLD: findings from NHANES (2017–2020)
4个月前
已完结
Operational merit of Controlled Attenuation Parameter and Liver Stiffness Measurement across grades of Metabolic Dysfunctional Associated Steatotic Liver Disease: A cross-sectional study
4个月前
已完结
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
5个月前
已完结
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
5个月前
已完结
Cardiovascular-Kidney-Metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD
5个月前
已完结
The role of mean platelet volume in metabolic dysfunction associated steatotic liver disease
5个月前
已完结
Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach
5个月前
已完结
皖公网安备34019202002308
